Consistent with current models, APOE allelic variants (e.g., ε2/ε3/ε4) modulate AD risk, while polymorphisms in adjacent genes such as TOMM40 and APOC1 also exhibit strong disease associations. This evidence concerns the gene APOC1 and Alzheimer disease.